Actively Recruiting
FAP-targeted PET/NIR in Lung Malignant Tumors
Led by Peking University People's Hospital · Updated on 2026-04-01
200
Participants Needed
1
Research Sites
134 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Single center, prospective, diagnostic study. Patients with stage II-IIIB resectable NSCLC diagnosed by pathology were included. After receiving standard neoadjuvant therapy (chemotherapy/immunotherapy/combination therapy), FAPI-PET/CT and fluorescence imaging were performed one week before surgery. During the surgery, a near-infrared fluorescence navigation system was used to locate the tumor lesion. After surgery, the tumor bed range was determined by pathological gold standards (HE staining+immunohistochemistry), and the predictive efficacy and localization accuracy of FAPI-PET/fluorescence were compared and analyzed.
CONDITIONS
Official Title
FAP-targeted PET/NIR in Lung Malignant Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 70 years old
- Have complete clinical and imaging data
- Prior biopsy pathology confirmed lung cancer before neoadjuvant therapy
- Able to provide sufficient tumor tissue for testing and research
- Signed informed consent
You will not qualify if you...
- History of other malignant tumors or prior anti-tumor treatments
- Insufficient tumor tissue collected for testing and research
- Neoadjuvant therapy duration less than 3 cycles
- Poor quality or missing multimodal probe PET dynamic scan images
- Lack of clinical and imaging data
- Considered inappropriate for participation by other researchers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking University People's Hospital
Beijing, Beijing Municipality, China
Actively Recruiting
Research Team
K
Kezhong Chen, MD
CONTACT
Q
Qingyun Liu, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here